Diabetes Clinical Trials in Minneapolis

Showing 221-240 of 260 trials

UCSD Take Charge Study

NCT01345500

The purpose of the Take Charge Study is to determine among overweight and obese men and women with type 2 diabetes whether 1) participating in a commercial weight loss program promotes great weight loss and weight loss maintenance at one year compared to usual care conditions and 2) whether there is a differential weight loss response to different dietary macronutrient composition (lower carbohydrate/higher fat diet versus a higher carbohydrate/lower fat).

OverweightObeseObesity+2 more

University of California, San Diego227 participantsStarted Feb 2012

La Jolla, California, United States • Minneapolis, Minnesota, United States

COMPLETEDNA< 1 mile

Impact of an Automated Telephone Intervention on Glycosylated Hemoglobin (HbA1c) in Type 2 Diabetes

NCT00700908

Aim 1. Determine the impact of a daily, automated telephone intervention on HbA1c levels compared to standard care in older patients with type 2 diabetes. Aim 2. Determine the impact of the automated telephone intervention compared to standard care on adherence to prescribed SMBG frequency in older patients with type 2 diabetes. Aim 3. Determine the impact of the automated telephone intervention compared to standard care on self-reported diabetic control problems in older patients with type 2 diabetes. Aim 4. Determine the impact of the automated telephone intervention compared to standard care on self-reported attitudes and health beliefs concerning diabetes in older patients with type 2 diabetes

Type 2 Diabetes

University of Minnesota120 participantsStarted Jun 2007

Minneapolis, Minnesota, United States

UCSD Take Charge Study

Impact of an Automated Telephone Intervention on Glycosylated Hemoglobin (HbA1c) in Type 2 Diabetes

Diabetes Trials in Other Cities

A Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney Function

DPBRN Blood Sugar Testing in Dental Patients

Screening for Early Evidence of Diabetes

WelChol® and Insulin in Treating Patients With Type 2 Diabetes

A 6 Week Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of GK1-399 in Type 2 Diabetes

Vascular Effects of Rosiglitazone Versus Glyburide in Type 2 Diabetic Patients

Pharmacokinetic, Safety/Tolerability Study of a Single SC Dose of PB1023 Injection in Subjects With Normal and Impaired Renal Function

Pharmacokinetic Profile of Two Formulations of PB1023 Following Single Subcutaneous Injection in Subjects With Type 2 Diabetes Mellitus

A Relative Bioavailability Study Measuring the Extent and Rate of Absorption of Different Tablet Formulations of AZD1656 in Type 2 Diabetes Mellitus (T2DM) Patients

Follow-Up Study for Exubera

Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus

Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy

Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus

A Study for Patients With Type 2 Diabetes Mellitus

Treatment Effect of Saxagliptin Compared With Placebo in Patients With Type 2 Diabetes and Renal Impairment

Testing the Developmental Origins Hypothesis

A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of CNTO 3649 in Healthy Adults and Patients With Type 2 Diabetes Mellitus

Lantus Versus NPH: Comparison in Insulin Naive People Not Adequately Controlled With at Least One Oral Anti Diabetics (OAD) Treatment

Other Conditions in Minneapolis